Population Health Research Institute (PHRI), McMaster University, Hamilton, ON L8L 2X2, Canada.
Department of Biochemistry, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India.
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):569-571. doi: 10.1016/j.dsx.2021.02.034. Epub 2021 Mar 3.
We aimed to study newly diagnosed diabetes in patients with mild to moderate COVID-19.
This was a retrospective cohort study of COVID-19 patients who were admitted to a tertiary care hospital in India from May to October 2020.
Of 102 patients, 21 (20.6%) had newly diagnosed diabetes on admission. Of which, four (19.0%) had marked hyperglycemia with no ketosis or ketoacidosis.
In this study of patients with mild to moderate COVID-19, newly diagnosed diabetes and marked hyperglycemia in those with newly diagnosed diabetes were common.
我们旨在研究轻度至中度 COVID-19 患者中的新发糖尿病。
这是一项回顾性队列研究，纳入了 2020 年 5 月至 10 月期间在印度一家三级保健医院住院的 COVID-19 患者。
在 102 名患者中，有 21 名（20.6%）在入院时被诊断为新发糖尿病。其中，有 4 名（19.0%）存在明显高血糖，但无酮症或酮酸中毒。
在这项对轻度至中度 COVID-19 患者的研究中，新发糖尿病和新发糖尿病患者的明显高血糖很常见。
